Globe Roche Logo

cobas® Influenza A/B Assay

We put a lab in a tube...

The cobas® Influenza A/B nucleic acid test, for use on the cobas® Liat® System, is an automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of Influenza A virus and Influenza B virus RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection in conjunction with clinical and epidemiological risk factors.

Features and Benefits

  • Small: The compact cobas® Liat® benchtop analyzer is smaller than a shoebox and conveniently designed for space-challenged testing locations
  • Simple: The cobas® Liat® System is fully-automated with touchscreen guided operation, requiring minimal training and hands-on time. Add nothing more than a patient sample.
  • Swift: Sample to results in 20 minutes or less. Single assay runs allow time-sensitive testing and reporting.
  • Secure: Sealed-tube design eliminates operator contact with reagents or other chemicals. Closed system with multiple controls reduce the potential for human error.

Intended Use

The test is intended for use as an aid in the differential diagnosis of Influenza A and Influenza B in humans and is not intended to detect Influenza C.

CE-IVD and 510(k) cleared and the CLIA waived. The cobas® Liat® System is not commercially available in all markets.